Breast cancer mortality rates have decreased in the U.S. due to advancements in detection and treatment, according to Dr. Christina Brar, a breast radiologist at UC San Francisco Fresno. Dr. Brar attributes this positive trend to earlier detection through screening, such as mammograms, and improved treatment options including surgery, radiation, chemotherapy, hormonal therapy, immunotherapy, and targeted therapy. She recommends annual mammograms for women starting at age 40, or earlier if there is a family history of the disease.
Despite progress in the U.S., breast cancer remains the leading cause of cancer death among women globally. Lower-income countries face significantly higher mortality rates due to limited access to essential screening, diagnosis, and comprehensive treatment services. This disparity underscores the ongoing challenges in achieving equitable breast cancer care worldwide.
To address these global inequities, organizations like the World Health Organization (WHO) are leading efforts for improved care. The WHO's Global Breast Cancer Initiative aims to reduce breast cancer mortality by 2.5% per year, aspiring to save 2.5 million lives by the year 2040. This initiative focuses on three core pillars: health promotion for early detection, timely diagnosis, and comprehensive treatment alongside supportive care, requiring substantial investment and collaboration.
